Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Avalo Therapeutics (AVTX) Tax Rate (2017 - 2025)

Avalo Therapeutics filings provide 9 years of Tax Rate readings, the most recent being 0.96% for Q4 2025.

  • On a quarterly basis, Tax Rate fell 63.0% to 0.96% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.21%, a 11.0% increase, with the full-year FY2025 number at 0.21%, up 11.0% from a year prior.
  • Tax Rate hit 0.96% in Q4 2025 for Avalo Therapeutics, down from 0.04% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 1.15% in Q2 2021 to a low of 0.96% in Q4 2025.
  • Median Tax Rate over the past 5 years was 0.04% (2022), compared with a mean of 0.03%.
  • Biggest five-year swings in Tax Rate: crashed -909bps in 2021 and later grew 19bps in 2023.
  • Avalo Therapeutics' Tax Rate stood at 0.08% in 2021, then crashed by -198bps to 0.08% in 2022, then skyrocketed by 235bps to 0.11% in 2023, then plummeted by -394bps to 0.32% in 2024, then tumbled by -196bps to 0.96% in 2025.
  • The last three reported values for Tax Rate were 0.96% (Q4 2025), 0.04% (Q3 2025), and 0.08% (Q2 2025) per Business Quant data.